Israel Hayom
-
08:48 Jan 28, 2024
Exero Medical's prospective, blinded, multi-center study of xBar has been approved by the WCG Clinical Services. Follow Israel Hayom on Facebook, Twitter, and Instagram The study, expected to commence during Q1 2024 at several leading US and Israeli hospitals, will enroll about 190 patients undergoing colorectal resection. It will evaluate the performance of Exero […]